Prognostic indicators of relapse-free and overall survival in patients with high-risk primary breast cancer following high-dose chemotherapy.

被引：0
|
作者：
Somlo, G
Chu, P
Frankel, P
Chow, W
Forman, S
Leong, L
Margolin, K
Morgan, R
Shibata, S
Yen, Y
Doroshow, J
机构：
[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Dept Biostat, Duarte, CA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
227
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?
    Nieto, Yago
    Shpall, Elizabeth J.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 150 - 157
  • [22] Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy
    Nieto, Y
    Nawaz, S
    Shpall, EJ
    Bearman, SI
    Murphy, J
    Jones, RB
    CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2609 - 2617
  • [23] High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer
    Ertz-Archambault, Natalie
    Northfelt, Donald W.
    Sonbol, Mohamad Bassam
    JAMA ONCOLOGY, 2020, 6 (08) : 1299 - 1300
  • [24] High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study
    Weiss, RB
    Rifkin, RM
    Stewart, FM
    Theriault, RL
    Williams, LA
    Herman, AA
    Beveridge, RA
    LANCET, 2000, 355 (9208): : 999 - 1003
  • [25] High-dose chemotherapy and hematopoietic stem cell rescue for metastatic and high-risk primary breast cancer
    Baynes, RD
    Klein, JL
    Dansey, RD
    Karanes, C
    Abella, E
    Akhtar, A
    Cassels, L
    Peters, WP
    BONE MARROW TRANSPLANTATION, 1998, 22 : S87 - S90
  • [26] Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer
    Barnett, Christine M.
    Heinrich, Michael C.
    Lim, Jeong
    Nelson, Dylan
    Beadling, Carol
    Warrick, Andrea
    Neff, Tanaya
    Higano, Celestia S.
    Garzotto, Mark
    Qian, David
    Corless, Christopher L.
    Thomas, George V.
    Beer, Tomasz M.
    CLINICAL CANCER RESEARCH, 2014, 20 (05) : 1306 - 1312
  • [27] Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer
    Kuzhan, Okan
    Oezet, Ahmet
    Ulutin, Cuneyt
    Koemuercue, Seref
    Arpaci, Fikret
    Oeztuerk, Bekir
    Oeztuerk, Mustafa
    TUMORI JOURNAL, 2007, 93 (06): : 550 - 556
  • [28] High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes
    Stuart, MJ
    Peters, WP
    Broadwater, G
    Hussein, A
    Ross, M
    Marks, LB
    Folz, RJ
    Long, GD
    Rizzieri, D
    Chao, NJ
    Vredenburgh, JJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (12) : 666 - 673
  • [29] Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer
    Recchia, Francesco
    Candeloro, Giampiero
    Rosselli, Michele
    Bratta, Massimo
    Pasta, Vittorio
    D'Orazi, Valerio
    Fumagalli, Luca A.
    Rea, Silvio
    ANTICANCER RESEARCH, 2015, 35 (12) : 6847 - 6853
  • [30] High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer Reply
    Steenbruggen, Tessa G.
    Steggink, Lars C.
    Sonke, Gabe S.
    JAMA ONCOLOGY, 2020, 6 (08) : 1300 - 1300
12345